A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.
about
Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?Overcoming tumor immune evasion with an unique arbovirusMechanism of Arctigenin-Induced Specific Cytotoxicity against Human Hepatocellular Carcinoma Cell Lines: Hep G2 and SMMC7721A small molecule SMAC mimic LBW242 potentiates TRAIL- and anticancer drug-mediated cell death of ovarian cancer cellsNatural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaBOvercoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cellsBortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity.Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer.Impact of hypoxia on the metastatic potential of human prostate cancer cells.Fas death receptor signalling: roles of Bid and XIAP.High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer.IAP antagonists sensitize murine osteosarcoma cells to killing by TNFαInhibitor of apoptosis proteins: fascinating biology leads to attractive tumor therapeutic targets.TRAIL-mediated signaling in prostate, bladder and renal cancer.Harnessing the cell death pathway for targeted cancer treatment.IAPs on the move: role of inhibitors of apoptosis proteins in cell migration.Proteomic tools for the characterization of cell death mechanisms in drug discovery.Carbon-ion beams effectively induce growth inhibition and apoptosis in human neural stem cells compared with glioblastoma A172 cells.Rotundarpene prevents TRAIL-induced apoptosis in human keratinocytes by suppressing the caspase-8- and Bid-pathways and the mitochondrial pathway.Menadione induces the formation of reactive oxygen species and depletion of GSH-mediated apoptosis and inhibits the FAK-mediated cell invasion.Identification of DR5 as a critical, NF-κB-regulated mediator of Smac-induced apoptosis.Parthenolide induces apoptosis by activating the mitochondrial and death receptor pathways and inhibits FAK-mediated cell invasion.Licochalcone A enhances geldanamycin-induced apoptosis through reactive oxygen species-mediated caspase activation.Brefeldin a induces apoptosis by activating the mitochondrial and death receptor pathways and inhibits focal adhesion kinase-mediated cell invasion.Physiologically based pharmacokinetic and pharmacodynamic modeling of an antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in a mouse xenograft model of human breast cancer.Ethanol promotes cytotoxic effects of tumor necrosis factor-related apoptosis-inducing ligand through induction of reactive oxygen species in prostate cancer cells.18β-glycyrrhetinic acid potentiates Hsp90 inhibition-induced apoptosis in human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathway.Combined effect of Hsp90 inhibitor geldanamycin and parthenolide via reactive oxygen species-mediated apoptotic process on epithelial ovarian cancer cells.Radicicol, an inhibitor of Hsp90, enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells by promoting activation of apoptosis-related proteins.Guanylate cyclase activator YC-1 enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells via activation of apoptosis-related proteins.Anti-proliferative and pro-apoptotic actions of a novel human and mouse ovarian tumor-associated gene OTAG-12: downregulation, alternative splicing and drug sensitization.Smac mimetic compounds potentiate interleukin-1beta-mediated cell deathCellular inhibitor of apoptosis 1 (cIAP-1) degradation by caspase 8 during TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.Differential response of head and neck cancer cell lines to TRAIL or Smac mimetics is associated with the cellular levels and activity of caspase-8 and caspase-103,4,5-Tricaffeoylquinic Acid Attenuates TRAIL-induced Apoptosis in Human Keratinocytes by Suppressing Apoptosis-related Protein Activation.Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy.IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells.
P2860
Q26771601-6F130672-83BA-4FCC-8988-5CA1510311DBQ28081774-8BC6F737-9263-41B5-BC4B-D13D8D825832Q28392953-6EB41FA4-AACB-4D50-ADF4-0E9430E5255AQ28482952-A8077896-B77C-427C-81EC-CC497620B1DBQ33775541-40130D37-283E-4AC0-83DE-0CAC359465F3Q33841579-ECBDF64A-8645-4119-9E4F-857E38145562Q34212347-AD5E2ADE-A286-4DAE-8D76-04D360846D0FQ34576976-B1B855F4-8C93-432C-870A-36632B218DD7Q35130362-663AD824-375A-4B21-B05A-A33303AFA359Q35186588-ADE77EC5-E97F-46A6-B159-EE0E4659340BQ35657414-C7F122A3-C44C-4765-B4D1-81DB3C54303CQ35782071-E6D56957-8970-4C6F-AF7C-7A76889501F4Q37376164-FA921CD1-5957-42B8-9197-690E70385265Q37875078-768301DA-120F-48C0-8C79-A574248D8E3DQ37889112-B784B375-3959-4683-9E2F-42EFDF9EA6F5Q37942090-E9B6F28C-0C23-44DB-A5C0-1B73BC525C54Q38134633-3B014B46-CB4E-40DE-B089-329230D66387Q38364625-3E8E03E6-6470-4652-999B-04A22557B4C9Q38864604-89779FC2-9775-46D5-A0C0-33BC08C45B67Q38951550-5B214CA3-9927-4C16-9365-B421DEDDBA93Q38989894-4D38C71B-3924-4613-8264-F381F0F57575Q39052447-9CFF8A50-DF33-4576-B1A0-9DA9E7A19EFCQ39092065-57DF5FC8-354A-4E5D-9068-53E7BADBA1F6Q39114307-1E0B8785-B3C2-451A-8A15-13A9E42EAAA8Q39130477-69A7F10F-4C94-40F9-8536-29D7252A20A0Q39132791-02C67E36-038E-4DA2-91CD-1BF1E8735853Q39276781-61E6C017-A309-45F9-B560-F8E1F6D21E05Q39302074-07E4C522-4432-4B8F-9B32-9D380D1CD3CAQ39376431-A3A4383B-16F3-4F2B-B93B-5BD1A7594309Q39498655-7563BF64-7666-463A-B4CC-8F9E8956A3F9Q39545932-71E20028-F95D-4642-B2D7-3A0DD27F1DF6Q39588369-E1718576-A5DA-4B72-89D6-F5EC71BABE73Q39642704-846B4BC4-0147-43DE-8FB5-6341BBD7846EQ41536623-2BC58611-D599-4395-8B7D-DDA6B47231E4Q42275527-434DD75F-0C12-404F-9AD3-7D1807143766Q46693050-806CB610-EB44-496F-9378-67561E4F53E8Q47221521-F852AB61-8466-47EE-B1E3-482CA6B95874Q47350839-30780AED-0811-42A9-AF21-7BE7629BAD57
P2860
A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A Smac-mimetic sensitizes pros ...... ating both IAPs and NF-kappaB.
@ast
A Smac-mimetic sensitizes pros ...... ating both IAPs and NF-kappaB.
@en
A Smac-mimetic sensitizes pros ...... ating both IAPs and NF-kappaB.
@nl
type
label
A Smac-mimetic sensitizes pros ...... ating both IAPs and NF-kappaB.
@ast
A Smac-mimetic sensitizes pros ...... ating both IAPs and NF-kappaB.
@en
A Smac-mimetic sensitizes pros ...... ating both IAPs and NF-kappaB.
@nl
prefLabel
A Smac-mimetic sensitizes pros ...... ating both IAPs and NF-kappaB.
@ast
A Smac-mimetic sensitizes pros ...... ating both IAPs and NF-kappaB.
@en
A Smac-mimetic sensitizes pros ...... ating both IAPs and NF-kappaB.
@nl
P2093
P2860
P356
P1433
P1476
A Smac-mimetic sensitizes pros ...... ating both IAPs and NF-kappaB.
@en
P2093
Jiqin Lian
Meilan Liu
Theodore S Lawrence
Wenhua Tang
Yongming Li
P2860
P2888
P356
10.1186/1471-2407-9-392
P407
P577
2009-11-06T00:00:00Z
P5875
P6179
1021896313